Listar Insuficiencia cardiaca avanzada e transplante cardiaco por autor "Sahuquillo-Martínez, Ana"

Mostrando ítems 1-2 de 2

    • Hyperkalemia in Heart Failure Patients in Spain and Its Impact on Guidelines and Recommendations: ESC-EORP-HFA Heart Failure Long-Term Registry 

      Crespo-Leiro, María Generosa; Barge-Caballero, Eduardo; Segovia-Cubero, Javier; González-Costello, José; López-Fernández, Silvia; García-Pinilla, José Manuel; Almenar-Bonet, Luis; Juan-Bagudá, Javier de; Roig-Minguell, Eulalia; Bayés-Genís, Antoni; Sanz-Julve, Marisa; Lambert Rodríguez, José Luis; Lara-Padrón, Antonio; Pérez-Ruiz, José María; Fernández-Vivancos Marquina, Carla; De la Fuente-Galán, Luis; Varela-Román, Alfonso; Torres-Calvo, Francisco; Andrés-Novales, Javier; Escudero-González, Aida; Pascual-Figal, Domingo A.; Ridocci-Soriano, Francisco; Sahuquillo-Martínez, Ana; Bierge-Valero, David; Epelde-Gonzalo, Francisco; Gallego-Page, Juan Carlos; Dalmau González-Gallarza, Regina; Bover-Freire, Ramón; Quiles-Granado, Juan; Pietro Maggioni, Aldo; Lund, Lars H.; Muñiz, Javier; Delgado Jiménez, Juan Francisco (Elsevier, 2020-04)
      [Abstract] Introduction and objectives: Hyperkalemia is a growing concern in the treatment of patients with heart failure and reduced ejection fraction because it limits the use of effective drugs. We report estimates of ...

    • Unravelling the Interplay Between Hyperkalaemia, Renin–Angiotensin–Aldosterone Inhibitor Use and Clinical Outcomes. Data From 9222 Chronic Heart Failure Patients of the ESC‐HFA‐EORP Heart Failure Long‐Term Registry 

      Rossignol, Patrick; Lainscak, Mitja; Crespo-Leiro, María Generosa; Laroche, Cécile; Piepoli, Massimo Francesco; Filippatos, Gerasimos; Rosano, Giuseppe; Savarese, Gianluigi; Anker, Stefan; Seferovic, Petar M.; Ruschitzka, Frank; Coats, Andrew J.S.; Mebazaa, Alexandre; McDonagh, Theresa; Sahuquillo-Martínez, Ana; Penco, María; Maggioni, Aldo P.; Lund, Lars H. (Willey Online Library, 2020-04-03)
      [Abstract] Aims. We assessed the interplay between hyperkalaemia (HK) and renin–angiotensin–aldosterone system inhibitor (RAASi) use, dose and discontinuation, and their association with all‐cause or cardiovascular death ...